• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    First-in-Class Investigational SX-682 Demonstrates Efficacy in Patients

    PRNEWSWIRE

    Syntrix Completes Initial SX-682 Dosing in Broad Phase 1/2 Cancer Trial

    PRNEWSWIRE

    Syntrix Discovers Desmetramadol is G-Protein Biased Opioid Receptor Agonist

    PR NEWSWIRE

    Syntrix Pharmaceuticals to Present +ve Desmetramadol Trial Results at the 2019

    PR NEWSWIRE

    Syntrix Pharmaceuticals` Positive Double-Blind Clinical Trials of Desmetramadol

    PR NEWSWIRE

    Syntrix Wins $3.4M NIH Grant to Conduct Phase 1/2 Trial of SX-682 in Myelodysplastic Syndrome

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.